ImageBiopsy Lab's CEO and co-founder Richard Ljuhar earned a prestigious nomination from the renowned Austrian platform, brutkasten, known for its recognition of outstanding achievements in the business and innovation landscape. Within the specific category of "Scale-ups," Richard navigated through a competitive voting period, ultimately emerging as the victorious recipient of the Innovator of the Year title.

‍

Long before the new hype triggered by ChatGPT around artificial intelligence (AI), ImageBiopsy Lab was considered one of the exemplary domestic companies in the field of AI. The Viennese scaleup has been active since 2016, utilizing artificial intelligence for medical diagnoses. CEO Richard Ljuhar founded the company together with Christoph Götz and Philip Meier. This year, ImageBiopsy Lab achieved another milestone: Squirrel, a software tool designed by the scaleup for detecting spinal diseases, received certification according to the EU Medical Devices Regulation – granting approval for the European market.- writes butkasten.media

‍

We are genuinely thrilled to receive this esteemed award, as it serves as a testament to the unwavering dedication and hard work of our entire team at ImageBiopsy Lab. Being recognized by the prestigious "Innovator of the Year" award is not just a reflection of our achievements but also an acknowledgment of our commitment to pushing boundaries in the field of AI-assisted radiological imaging.

Our journey at ImageBiopsy Lab has been marked by a pioneering spirit, particularly in unlocking new frontiers within the domestic market for AI-driven medical imaging. We have consistently demonstrated our commitment to excellence by successfully navigating the intricate processes involved in obtaining CE and, to some extent, FDA certifications. These certifications underscore our steadfast dedication to upholding the highest standards, ensuring that our technologies meet and exceed the stringent regulatory requirements.

As we celebrate this achievement, we are particularly proud of our latest product, IBLab FLAMINGO. This cutting-edge solution represents a significant leap forward in the detection of osteoporotic fractures within computed tomographies, showcasing our commitment to pushing the boundaries of medical technology.

In essence, this award is not just a recognition of past accomplishments but an encouragement to continue our journey of making sustainable and impactful changes in the healthcare sector. We are grateful for the acknowledgment of our collaborative efforts, and it motivates us to persist in our pursuit of advancing healthcare through innovation.

‍

About Brutkasten: 

"The Brutkasten" is the focal point of the Austrian startup scene. Every day, they passionately and meticulously produce content for and with founders, corporates, investors, and all those interested in the domestic innovation economy.